简报 口服抗衰 抗衰低龄化趋势显著，口服抗衰迎来升级革命 概览标签：口服抗衰、新兴抗衰成分 China Oral anti-aging 中国経口抗衰産業 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。未经头豹研究院事先书面许可，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改 编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹 研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名称之外的其他分支机构 ，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 头豹研究院 1 Chapter 1 口服抗衰 行业综述 www.leadleo.com 400-072-5588 2 ❑ 定义及分类 ❑ 消费者洞察 ❑ 市场参与者 ❑ 发展趋势 简报 | 2025/09 口服抗衰 口服抗衰的定义及分类 3 抗衰需求已从"中老年专属"向全年龄段渗透。口服抗衰指的是通过口服特定 营养成分、生物活性物质，辅助调节体内生理机制、延缓细胞老化，进而维 ...

简报 口服抗衰 抗衰低龄化趋势显著，口服抗衰迎来升级革命 概览标签：口服抗衰、新兴抗衰成分 China Oral anti-aging 中国経口抗衰産業 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。未经头豹研究院事先书面许可，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改 编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹 研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名称之外的其他分支机构 ，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 头豹研究院 1 Chapter 1 口服抗衰 行业综述 来源：食研汇、头豹研究院 www.leadleo.com 400-072-5588 2 ❑ 定义及分类 ❑ 消费者洞察 ❑ 市场参与者 ❑ 发展趋势 简报 | 2025/09 口服抗衰 口服抗衰的定义及分类 抗衰需求已从"中老年专属"向全年龄段渗透。口服抗衰指的是通过口服特定 营养成分、生物活性物质，辅助调节体内生理机制、 ...

简报 口服抗衰 抗衰低龄化趋势显著，口服抗衰迎来升级革命 概览标签：口服抗衰、新兴抗衰成分 China Oral anti-aging 中国経口抗衰産業 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。 ，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改 编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹 研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名称之外的其他分支机构 ，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 头豹研究院 1 Chapter 1 口服抗衰 行业综述 衰老的标志 基因组不稳定性 端粒磨损 表观遗传改变 蛋白质稳态丧失 菌群失调 营养感应失调 线粒体功能障碍 细胞衰老 细胞自噬失能 细胞间通讯改变 慢性炎症 细胞外基质变化 心理-社会隔离 干细胞耗竭 衰老引发的常见疾病 眼部疾病 听力损失 皮肤衰老 心脑血管疾病 神经退行性变 代谢系统疾病 呼吸系统疾病 泌尿系统疾病 生殖系统疾病 骨骼关节疾病 ...

Core Insights - The article discusses the transformative potential of biomanufacturing, which utilizes microorganisms to create sustainable products, thereby reducing reliance on fossil fuels and minimizing environmental impact [1][2][4]. Group 1: Biomanufacturing Overview - Biomanufacturing is defined as a process where microorganisms convert renewable resources into valuable products, such as biodegradable plastics and high-performance materials [2][3]. - The shift from traditional petrochemical-based production to biomanufacturing is seen as essential for achieving a more sustainable industrial model [2][4]. Group 2: Economic Impact and Market Potential - The biomanufacturing industry in China is approaching a total scale of nearly 1 trillion yuan, driven by policy support and capital investment [6]. - Utilizing agricultural waste, such as crop straw, could potentially generate over 1 million tons of biodegradable plastic annually, creating a market worth hundreds of billions [5][6]. Group 3: Industry Development and Collaboration - Companies like Kasei Biotech are forming strategic partnerships to develop biobased materials, demonstrating a collaborative approach to building a competitive biomanufacturing ecosystem [7]. - The integration of biomanufacturing in various sectors, including healthcare and consumer products, is expanding, with companies innovating in areas like biodegradable medical materials and low-sugar food products [8]. Group 4: Challenges and Barriers - The biomanufacturing sector faces challenges in scaling up from laboratory to industrial production, particularly in optimizing microbial strains and production processes [9][10]. - Regulatory hurdles and slow approval processes for genetically engineered strains hinder the speed of innovation and market entry for new biomanufactured products [9][10].

Core Viewpoint - The establishment of the Oral Beauty Nutrition Branch of the Beijing Nutrition Society marks a new phase of standardization and professionalism in the oral beauty industry, aiming to integrate scientific research, standard construction, popular science education, and industrial development [4][6]. Group 1: Industry Development - The oral beauty market in China is projected to exceed 25.57 billion yuan by 2025, with a compound annual growth rate (CAGR) of over 3.8%, and it is expected to become the largest oral beauty market globally by 2030 [4]. - The market is witnessing a diversification of ingredients, with collagen products expected to hold a 42% market share in 2024, and oral hyaluronic acid showing the fastest growth with a year-on-year sales increase of 58% [6][4]. - New nutritional ingredients such as ergothioneine and PQQ are also showing significant growth potential, with ergothioneine expected to grow by 25% in the health food market in 2024 [6]. Group 2: Scientific Contributions - The Oral Beauty Nutrition Branch aims to provide a comprehensive platform for scientific research and market practice, offering scientific basis and normative guidance for product development and efficacy evaluation [4][6]. - The "Oral Beauty Nutrition Ingredient Popular Science Handbook" was released, featuring nine popular ingredients and four new oral beauty nutrition technologies, providing a systematic and authoritative guide for the public [9]. - Experts at the event discussed the benefits of key ingredients such as collagen peptides, EGCG, and astaxanthin, highlighting their roles in skin health and anti-aging [10][12]. Group 3: Organizational Structure - The first committee of the Oral Beauty Nutrition Branch consists of 41 members, with Professor Luo Yongkang elected as the chairman and several other experts appointed as vice-chairmen and secretary [6][4]. - The branch will collaborate with regulatory bodies, medical institutions, research institutes, and enterprises to establish a long-term cooperative mechanism to promote the development of the oral beauty nutrition industry [6].

Core Viewpoint - Zhejiang Kemin Biopharmaceutical Co., Ltd. is advancing its production capabilities by launching a project to produce 1,400 tons of bio-fermentation products annually, focusing on environmentally friendly alternatives to previously planned products [1][2]. Project Overview - Project Name: Annual production of 1,400 tons of bio-fermentation series products and supporting construction project [2] - Project Nature: Technological upgrade [2] - Construction Unit: Zhejiang Kemin Biopharmaceutical Co., Ltd. [2] - Location: Zhejiang Xinchang Economic Development Zone [2] - Scale: The project includes two adjacent closed production lines, one for fermentation processes and another for extraction processes, with advanced equipment to achieve a production capacity of 1,400 tons per year [2]. Product Details - The project will produce various bio-fermentation products, including: - Coenzyme Q10: 1,080 tons/year - Astaxanthin: 100 tons/year - Calcium Pantothenate: 1,090 tons/year - Beta-Carotene: 60 tons/year - Lycopene: 3 tons/year - PQQ: 7 tons/year - Dehydroacetic Acid: 60 tons/year [2]. Financial Performance - Zhejiang Pharmaceutical Co., Ltd. expects a net profit attributable to shareholders of 600 million to 720 million yuan for the first half of 2025, representing a year-on-year increase of 90.28% to 128.33% [2]. - The net profit excluding non-recurring gains and losses is projected to be between 590 million and 708 million yuan, reflecting an increase of 86.27% to 123.53% year-on-year [2]. Market Dynamics - The company is focusing on maintaining safety in production and product quality amidst intense market competition and a complex economic environment [3]. - The demand and sales prices for the company's main products in the life nutrition segment have increased compared to the same period last year, driving revenue growth [3]. Industry Event - The 4th Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22, 2025, in Ningbo, Zhejiang, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, and agriculture [4][6].

Core Insights - The health consumption market is transitioning from a passive "treatment" mindset to an active "prevention" approach, driven by policy, technology, and consumer upgrades [1][28] - The report identifies five consumer segments, each with distinct health management preferences and behaviors [1][49] Group 1: Consumer Trends - Health is becoming a core aspect of beauty, with non-prescription drugs and oral beauty products gaining popularity [2] - Weight management is a key focus, with scientific weight loss principles and innovative food products emerging [2] - The concept of "preventive health" is gaining traction, emphasizing dietary and lifestyle habits [2] - Emotional well-being is increasingly recognized, with consumers using purchases as a means to cope with emotions [2] Group 2: Market Dynamics - The health consumption market is experiencing a supply-demand restructuring, with a shift towards personalized health solutions [33] - The market is expanding across various categories, including "health + home," "health + pets," and "health + beauty" [35] - The pharmaceutical market in China reached approximately 14,480 billion yuan in 2020, with a projected compound annual growth rate of 9.6% over the next five years [35] Group 3: Consumer Segmentation - The report categorizes consumers into five segments: 1. High-intelligence action-oriented individuals who prioritize authoritative endorsements and transparent efficacy [1][49] 2. Passive followers who respond to external health trends and are influenced by social media [1][49] 3. Family health managers focused on disease prevention and safety of ingredients [1][49] 4. Relaxed wellness enthusiasts who practice balanced diets and prefer traditional health products [1][49] 5. Emotionally healing individuals who seek professional psychological support and smart companionship devices [1][49] Group 4: Challenges and Solutions - The industry faces challenges such as information overload, brand trust crises, and the need for clearer health narratives [40] - The TRUTH principle proposed by CBNData aims to address these challenges by establishing a cognitive benchmark and rebuilding trust mechanisms [40]

Group 1: Company Overview - The company primarily engages in the research, production, and sales of nutritional health foods (including raw materials and finished products) and feed additives [2][3] - The production of health food raw materials and feed additives mainly occurs domestically, with a high export ratio; finished health food products are primarily produced and sold overseas, showing significant growth through cross-border e-commerce [3] Group 2: Product Development and Market Position - The company utilizes synthetic biology as a foundational technology for large-scale production of various raw materials, including Coenzyme Q10, NMN, NADH, Vitamin K2, and others [3] - Coenzyme Q10 holds the largest global market share, demonstrating notable cost and scale advantages [3] - The company aims to reduce production costs for products like astaxanthin, DHA, and EPA to enhance market competitiveness [3] Group 3: Brand and Sales Strategy - The company owns two major health food brands, Doctor's Best and Zipfizz, with production capabilities for capsules, tablets, and powders [3][4] - Doctor's Best is a well-known health brand in North America, showing steady growth, while Zipfizz maintains stable performance with new products developed for the U.S. market [4] - The marketing strategy for domestic health food business focuses on market insights, product strategy, resource integration, and data-driven upgrades to create market-leading products [4] Group 4: Financial Performance - The company's performance growth in the first half of 2025 is primarily attributed to increased sales of Coenzyme Q10, vitamins, and domestic health products [3]

Group 1: Company Operations - The company has successfully completed a 1.5 times expansion of its coenzyme Q10 raw material production line, with new fermentation tanks successfully tested and currently maintaining a strong production and sales momentum [2][3] - The price of Vitamin A has decreased due to market fluctuations, while DHA products have improved competitiveness through technological upgrades and market promotion, laying a solid foundation for future market expansion [2][3] - Other raw material products such as astaxanthin and Vitamin K2 are showing significant positive trends [3] Group 2: Market Expansion and Product Development - The company's health food finished product business is expanding well in the domestic market, benefiting from the rapid development of the domestic health consumption industry [3] - The overseas subsidiary VitaBest's soft capsule production line is under construction and is expected to be operational in the second half of the year; Zipfizz functional beverages will introduce four new flavors and a new "YOU" ready-to-drink product series [3] Group 3: Regulatory and Market Challenges - The current tariff rate for coenzyme Q10, Vitamin A, Vitamin D3, and Vitamin K2 exported to the U.S. is 20%. The company has mitigated the tariff impact by raising sales prices or having downstream customers bear the tariff costs; the sales proportion of vitamin products in the U.S. is small, limiting the overall impact [3] Group 4: Marketing Strategies - The company plans to develop marketing strategies for end-nutrition health products based on industry characteristics, market demand, brand positioning, and resource integration capabilities, utilizing market insights and data-driven approaches to create market-leading products [3] Group 5: Synthetic Biology Applications - The company employs synthetic biology as a foundational technology for the large-scale production of various raw material products, including coenzyme Q10, NMN, NADH, Vitamin K2, nattokinase, PQQ, SAMe, DHA, and ARA, while also exploring new products such as astaxanthin, algal oil EPA, glutathione, inositol, calcium pantothenate, and biological sweeteners [3]